Recently, several studies have reported that LTF was downregulated and may act as a tumor suppressor in several types of cancer such as prostate cancer, clear cell renal cell carcinoma, oral squamous cell carcinoma and nasopharyngeal carcinoma. This evidence concerns the gene LTF and clear cell renal carcinoma.